Board of Pharmacy rule relating to licensure and practice of pharmacy
Summary
SB 358 is a bill relating to a Board of Pharmacy rule governing licensure and the practice of pharmacy. Based on the caption, the measure appears to address how pharmacists and pharmacy-related professionals are licensed, regulated, or permitted to practice under state law, likely by approving, modifying, or otherwise affecting an administrative rule from the Board of Pharmacy.
Because the bill text was not available in the provided materials, the specific statutory changes cannot be identified from the record here. However, the bill would likely affect the state’s pharmacy regulatory framework, including the Board of Pharmacy’s authority, licensure standards, and any practice requirements for pharmacists, pharmacies, or related permit holders. The bill was referred to the Judiciary Committee, indicating it may involve legal or regulatory issues beyond routine administrative approval.
Impact
SB 358 likely affects West Virginia’s pharmacy licensing and practice statutes or the implementation of Board of Pharmacy rules, with practical consequences for pharmacists, pharmacies, and other regulated licensees. If enacted, it could alter professional standards, scope-of-practice requirements, or administrative procedures tied to pharmacy regulation. The referral to Judiciary suggests the bill may have legal implications for how the rule interacts with existing law or the board’s rulemaking authority.
Sentiment
No committee transcript or vote record was provided, so there is no direct evidence of support, opposition, or amendment debate in the available materials. The bill’s referral to Judiciary suggests it was treated as a legal/regulatory measure requiring further review rather than a purely technical update. Overall sentiment cannot be determined from the provided record.
Contention
The main potential point of contention is the scope of the Board of Pharmacy’s rulemaking authority and whether the rule appropriately balances professional regulation, public safety, and access to pharmacy services. Stakeholders who could be affected include pharmacists, pharmacy owners, pharmacy technicians, and patients, particularly if the rule changes licensure requirements or practice limitations. Without transcripts or votes, however, no specific objections or supporters can be identified.